In vitro fertilizationA detailed cost analysis of in vitro fertilization and intracytoplasmic sperm injection treatment
Section snippets
Materials and methods
Detailed cost data were collected during a national study that was performed from January 2002 through December 2004. All 13 Dutch IVF centers and transport clinics (n = 23) were invited to participate. Within this study, detailed cost data were collected, which made the present costing study possible.
This micro-costing study is based on the 2002 data of resource use and unit prices that were collected at four IVF centers: two academic and two nonacademic IVF centers that were assumed to be
Stage 1
The costs of hormonal stimulation consisted of the cost of the fertility department and cost of medication. The mean number of visits to the IVF center during the hormonal stimulation stage was three. Among the fertility departments, the cost of hormonal stimulation varied from €179 to €220. The average amount of recombinant FSH per IVF/ICSI cycle was 2370 IU (SD 1095) per stimulation.
Overall, the mean total cost of medication (GnRH agonists, recombinant FSH, hCG) per stimulation cycle was
Discussion
The 2004 average costs per started IVF and ICSI treatment cycle were €2381 and €2578, respectively, and the costs per ongoing pregnancy were €10,482 and €10,036. Examining the different cost components per treatment cycle, it is evident that the hormonal stimulation stage is the most expensive part of IVF and ICSI, followed by the stage of oocyte retrieval (Fig. 1).
Costs of medication constituted more than half of the total costs for both IVF and ICSI (61% and 55%, respectively). Approximately
Acknowledgments
The authors thank all of the gynecologists, fertility physicians and nurses, embryologists and laboratory technicians, and everyone else who provided the data on which our study is based. We thank A. Wetzels (IVF Laboratory, University Medical Centre Nijmegen) for his support in calculating laboratory costs.
References (22)
- et al.
Intrauterine insemination or in-vitro fertilisation in idiopathic subfertility and male subfertility: a randomised trial and cost-effectiveness analysis
Lancet
(2000) - et al.
A Markov model of the cost-effectiveness of human derived follicle-stimulating hormone (FSH) versus recombinant FSH using comparative clinical data
Fertil Steril
(2005) - et al.
Economic evaluation of highly purified menotropin compared with recombinant follicle-stimulating hormone in assisted reproduction
Fertil Steril
(2003) - et al.
Analysis of the cost effectiveness of recombinant versus urinary follicle-stimulating hormone in in vitro fertilization/intracytoplasmic sperm injection programs in the United States
Fertil Steril
(2002) - et al.
Results of in vitro fertilization in the Netherlands, 1996–2000
Ned Tijdschr Geneeskd
(2002) An international survey of the health economics of IVF and ICSI
Hum Reprod
(2002)- et al.
Handleiding voor kostenonderzoek, methoden en standaard kostprijzen voor economische evaluaties in de gezondheidszorg
(2004) - et al.
Clinical complications during in-vitro fertilization treatment
Hum Reprod
(1992) - Kremer J. National IVF figures 2004. Available at:...
Individualized cost-effective conventional ovulation induction treatment in normogonadotrophic anovulatory infertility (WHO group 2)
Hum Reprod
Cited by (0)
Supported by research grant (number 945-12-013) from the Dutch Organisation for Health Research and Development (ZonMW).